PIP-AMITRIPTYLINE amitriptyline hydrochloride 50mg tablet blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

amitriptyline hydrochloride, Quantity: 50 mg

Pieejams no:

Ipca Pharma (Australia) Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

amitriptyline hydrochloride

Zāļu forma:

Tablet

Kompozīcija:

Excipient Ingredients: purified talc; hypromellose; macrogol 6000; sunset yellow FCF aluminium lake; microcrystalline cellulose; lactose monohydrate; titanium dioxide; crospovidone; maize starch; magnesium stearate; colloidal anhydrous silica; indigo carmine aluminium lake

Ievadīšanas:

Oral

Vienības iepakojumā:

20, 50 and 100

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

For the treatment of major depression. Amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,Nocturnal enuresis where organic pathology has been excluded.

Produktu pārskats:

Visual Identification: Brown colour, circular, biconvex, film coated tablets with 'IA' over '50' debossed on one side and plain on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizācija statuss:

Licence status A

Autorizācija datums:

2014-08-22